| 臺大學術典藏 |
2021-07-03T03:34:35Z |
Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: Genotype B vs C
|
Liu C.-J.; Cheng H.-R.; Chen C.-L.; Chen T.-C.; Tseng T.-C.; Wang Z.-L.; PEI-JER CHEN; Liu C.-H.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:34Z |
Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan
|
PEI-JER CHEN; Lin J.-J.; Lu C.-S.; Ong C.-T.; Hsieh P.F.; Yang C.-C.; Tai C.-T.; Wu S.-L.; Lu C.-H.; Hsu Y.-C.; Yu H.-Y.; Ro L.-S.; Lu C.-T.; Chu C.-C.; Tsai J.-J.; Su Y.-H.; Lan S.-H.; Sung S.-F.; Lin S.-Y.; Chuang H.-P.; Huang L.-C.; Chen Y.-J.; Tsai P.-J.; Liao H.-T.; Lin Y.-H.; Chen C.-H.; Chung W.-H.; Hung S.-I.; Wu J.-Y.; Chang C.-F.; Chen L.; Chen Y.-T.; Shen C.-Y. |
| 臺大學術典藏 |
2021-07-03T03:34:34Z |
Phase I dose-finding study of pazopanib in hepatocellular carcinoma: Evaluation of early efficacy, pharmacokinetics, and pharmacodynamics
|
Yau T.; PEI-JER CHEN; Chan P.; Curtis C.M.; Murphy P.S.; Suttle A.B.; Gauvin J.; Hodge J.P.; Dar M.M.; Poon R.T. |
| 臺大學術典藏 |
2021-07-03T03:34:34Z |
Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data
|
Tao Y.; Ruan J.; Yeh S.-H.; Lu X.; Wang Y.; Zhai W.; Cai J.; Ling S.; Gong Q.; Chong Z.; Qu Z.; Li Q.; Liu J.; Yang J.; Zheng C.; Zeng C.; Wang H.-Y.; Zhang J.; Wang S.-H.; Hao L.; Dong L.; Li W.; Sun M.; Zou W.; Yu C.; Li C.; Liu G.; Jianga L.; Xu J.; Huang H.; Li C.; Mi S.; Zhang B.; Chen B.; Zhao W.; Hu S.; Zhuang S.-M.; Shen Y.; Shi S.; Brown C.; White K.P.; Chen D.-S.; PEI-JER CHEN; Wu C.-I. |
| 臺大學術典藏 |
2021-07-03T03:34:33Z |
New variants and age shift to high fatality groups contribute to severe successive waves in the 2009 influenza pandemic in Taiwan
|
Yang J.-R.; Huang Y.-P.; Chang F.-Y.; Hsu L.-C.; Lin Y.-C.; Su C.-H.; PEI-JER CHEN; Wu H.-S.; Liu M.-T. |
| 臺大學術典藏 |
2021-07-03T03:34:33Z |
HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain
|
Kulkantrakorn K.; Tassaneeyakul W.; Tiamkao S.; Jantararoungtong T.; Prabmechai N.; Vannaprasaht S.; Chumworathayi P.; PEI-JER CHEN; Sritipsukho P. |
| 臺大學術典藏 |
2021-07-03T03:34:33Z |
Use of RNA interference to modulate liver adenoma development in a murine model transgenic for hepatitis B virus
|
Chen C.-C.; Chang C.-M.; Sun C.-P.; Yu C.-P.; Wu P.-Y.; Jeng K.-S.; Hu C.-P.; PEI-JER CHEN; Wu J.-C.; Shih C.-H.; Gershwin M.E.; Tao M.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:33Z |
Depletion of β-catenin from mature hepatocytes of mice promotes expansion of hepatic progenitor cells and tumor development
|
Wang E.-Y.; Yeh S.-H.; Tsai T.-F.; Huang H.-P.; Jeng Y.-M.; Lin W.-H.; Chen W.-C.; Yeh K.-H.; PEI-JER CHEN; Chen D.-S. |
| 臺大學術典藏 |
2021-07-03T03:34:32Z |
Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters
|
Tseng T.-C.; Liu C.-J.; Chen C.-L.; Wang C.-C.; Su T.-H.; Kuo S.F.-T.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:32Z |
High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load
|
Tseng T.-C.; Liu C.-J.; Yang H.-C.; Su T.-H.; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:32Z |
Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma
|
Kao J.-H.; Liu C.-J.; Jow G.-M.; PEI-JER CHEN; Chen D.-S.; Chen B.-F. |
| 臺大學術典藏 |
2021-07-03T03:34:31Z |
Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors
|
Huang C.-H.; Yuan Q.; PEI-JER CHEN; Zhang Y.-L.; Chen C.-R.; Zheng Q.-B.; Yeh S.-H.; Yu H.; Xue Y.; Chen Y.-X.; Liu P.-G.; Ge S.-X.; Zhang J.; Xia N.-S. |
| 臺大學術典藏 |
2021-07-03T03:34:31Z |
Hepatitis B virus nucleocapsid but not free core antigen controls viral clearance in mice
|
Lin Y.-J.; Wu H.-L.; Chen D.-S.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:31Z |
Impact of hepatitis B virus infection on metabolic profiles and modifying factors
|
Hsu C.-S.; Liu C.-H.; Wang C.-C.; Tseng T.-C.; Liu C.-J.; Chen C.-L.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:31Z |
Emerging hepatitis B virus infection in vaccinated populations: A rising concern?
|
Su T.-H.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:30Z |
Host genetic variants and hepatitis b virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission
|
Lin C.-L.; Tseng T.-C.; Su T.-H.; Liu C.-J.; PEI-JER CHEN; Lai M.-Y.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:30Z |
Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity
|
Chen K.-F.; Tai W.-T.; Hsu C.-Y.; Huang J.-W.; Liu C.-Y.; PEI-JER CHEN; Kim I.; Shiau C.-W. |
| 臺大學術典藏 |
2021-07-03T03:34:30Z |
Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B
|
Pan C.J.-H.; Wu H.-L.; Kuo S.F.-T.; Kao J.-H.; Tseng T.-C.; Liu C.-H.; PEI-JER CHEN; Liu C.-J.; Chen D.-S. |
| 臺大學術典藏 |
2021-07-03T03:34:30Z |
Long-term results of a randomized, observation-controlled, phase III Trial of Adjuvant Interferon alfa-2b in hepatocellular carcinoma after curative resection
|
Chen L.-T.; Chen M.-F.; Li L.-A.; Lee P.-H.; Jeng L.-B.; Lin D.-Y.; Wu C.-C.; Mok K.-T.; Chen C.-L.; Lee W.-C.; Chau G.-Y.; Chen Y.-S.; Lui W.-Y.; Hsiao C.-F.; Whang-Peng J.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:29Z |
Estrogen receptor α represses transcription of HBV genes via interaction with hepatocyte nuclear factor 4α
|
Wang S.-H.; Yeh S.-H.; Lin W.-H.; Yeh K.-H.; Yuan Q.; Xia N.-S.; Chen D.-S.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:29Z |
HBeAg(+) and sex ratio of offspring: Evidence form Taiwan's three million newborns
|
Lin M.-J.; PEI-JER CHEN; Luoh M.-C. |
| 臺大學術典藏 |
2021-07-03T03:34:29Z |
Synthesis and biological activity of obatoclax derivatives as novel and potent SHP-1 agonists
|
Su J.-C.; Chen K.-F.; Chen W.-L.; Liu C.-Y.; Huang J.-W.; Tai W.-T.; PEI-JER CHEN; Kim I.; Shiau C.-W. |
| 臺大學術典藏 |
2021-07-03T03:34:28Z |
A highly specific ELISA for diagnosis of 2009 influenza A (H1N1) virus infections
|
Lu C.-Y.; Chang L.-Y.; PEI-JER CHEN; Xia N.-S.; Shao P.-L.; Huang L.-M. |
| 臺大學術典藏 |
2021-07-03T03:34:28Z |
Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:28Z |
Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load
|
Tseng T.-C.; Liu C.-J.; Yang H.-C.; Su T.-H.; Wang C.-C.; Chen C.-L.; Fang-Tzu Kuo S.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:27Z |
Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3
|
Tai W.-T.; Cheng A.-L.; Shiau C.-W.; Liu C.-Y.; Ko C.-H.; Lin M.-W.; PEI-JER CHEN; Chen K.-F. |
| 臺大學術典藏 |
2021-07-03T03:34:27Z |
Androgen pathway stimulates MicroRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis
|
PEI-JER CHEN; Yeh S.-H.; Liu W.-H.; Lin C.-C.; Huang H.-C.; Chen C.-L.; Chen D.-S.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:27Z |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:27Z |
High-resolution melting and real-time PCR for quantification and detection of drug-resistant HBV mutants in a single amplicon
|
Hsiao C.-C.; Chang J.; Wu J.-Y.; Liu W.-H.; Han S.-Y.; PEI-JER CHEN; Yeh S.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:26Z |
PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model
|
Tzeng H.-T.; Tsai H.-F.; Liao H.-J.; Lin Y.-J.; Chen L.; PEI-JER CHEN; Hsu P.-N. |
| 臺大學術典藏 |
2021-07-03T03:34:26Z |
Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3
|
Chen K.-F.; Chen H.-L.; Liu C.-Y.; Tai W.-T.; Ichikawa K.; PEI-JER CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-03T03:34:26Z |
Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy
|
Sheng W.-H.; Hung C.-C.; Chang S.-Y.; Liu C.-J.; Chen M.-Y.; Hsieh S.-M.; Kao J.-H.; PEI-JER CHEN; Chang S.-C. |
| 臺大學術典藏 |
2021-07-03T03:34:25Z |
Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivation
|
Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:25Z |
Re-evaluation of the Carcinogenic Significance of Hepatitis B Virus Integration in Hepatocarcinogenesis
|
Jiang S.; Yang Z.; Li W.; Li X.; Wang Y.; Zhang J.; Xu C.; PEI-JER CHEN; Hou J.; McCrae M.A.; Chen X.; Zhuang H.; Lu F. |
| 臺大學術典藏 |
2021-07-03T03:34:25Z |
Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia
|
Afdhal N.H.; Giannini E.G.; Tayyab G.; Mohsin A.; Lee J.-W.; Andriulli A.; Jeffers L.; McHutchison J.; PEI-JER CHEN; Han K.-H.; Campbell F.; Hyde D.; Brainsky A.; Theodore D. |
| 臺大學術典藏 |
2021-07-03T03:34:25Z |
Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells
|
Chen K.-F.; Lin J.-P.; Shiau C.-W.; Tai W.-T.; Liu C.-Y.; Yu H.-C.; PEI-JER CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-03T03:34:24Z |
IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients
|
Hsu C.-S.; Hsu S.-J.; Liu W.-L.; Chen C.-L.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:24Z |
A systematic review and meta-analysis of adjuvant interferon therapy after curative treatment for patients with viral hepatitis-related hepatocellular carcinoma
|
Huang T.-S.; Shyu Y.-C.; Chen H.-Y.; Yuan S.-S.; Shih J.-N.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:24Z |
Influences of tobacco and alcohol use on hepatocellular carcinoma survival
|
Shih W.-L.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN; Liu C.-J.; Lin C.-L.; Yu M.-W. |
| 臺大學術典藏 |
2021-07-03T03:34:23Z |
Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells
|
Tai W.-T.; Shiau C.-W.; Chen H.-L.; Liu C.-Y.; Lin C.-S.; Cheng A.-L.; PEI-JER CHEN; Chen K.-F. |
| 臺大學術典藏 |
2021-07-03T03:34:23Z |
Predicting clinical outcome in a patient with chronic hepatitis B virus infection
|
Yang H.-I.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:23Z |
Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy
|
Huang Y.-W.; Lin S.-C.; Wei S.-C.; Hu J.-T.; Chang H.-Y.; Huang S.-H.; Chen D.-S.; PEI-JER CHEN; Hsu P.-N.; Yang S.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:23Z |
Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia
|
Chen D.-S.; Locarnini S.; Wait S.; Bae S.-H.; PEI-JER CHEN; Fung J.Y.Y.; Kim H.S.; Lu S.-N.; Sung J.; Tanaka J.; Wakita T.; Ward J.; Wallace J. |
| 臺大學術典藏 |
2021-07-03T03:34:22Z |
Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol.
|
Huang T.S.; Shyu Y.C.; Turner R.; Chen H.Y.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:22Z |
Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody
|
Chen K.-F.; Chen H.-L.; Shiau C.-W.; Liu C.-Y.; Chu P.-Y.; Tai W.-T.; Ichikawa K.; PEI-JER CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-03T03:34:22Z |
A real-time convective PCR machine in a capillary tube instrumented with a CCD-based fluorometer
|
Hsieh Y.-F.; Lee D.-S.; Chen P.-H.; Liao S.-K.; Yeh S.-H.; PEI-JER CHEN; Yang A.-S. |
| 臺大學術典藏 |
2021-07-03T03:34:22Z |
Hepatitis B virus reactivation in patients receiving cancer chemotherapy: Natural history, pathogenesis, and management
|
Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:21Z |
Immunocompetent nontransgenic mouse models for studying hepatitis B virus immune responses
|
Tzeng H.-T.; Hsu P.-N.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:21Z |
Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients
|
Yuan Q.; Song L.-W.; Liu C.-J.; Li Z.; Liu P.-G.; Huang C.-H.; Yan Y.; Ge S.-X.; Wang Y.-B.; Peng C.-Y.; Zhang J.; Kao J.-H.; Chen D.-S.; PEI-JER CHEN; Xia N.-S. |
| 臺大學術典藏 |
2021-07-03T03:34:21Z |
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion
|
Yang H.-C.; Chen C.-L.; Shen Y.-C.; Peng C.-Y.; Liu C.-J.; Tseng T.-C.; Su T.-H.; Chuang W.-L.; Yu M.-L.; Dai C.-Y.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
